Want to join the conversation?
At the midpoint, $CCI's updated full year 2015 outlook for AFFO per share of $4.30 is up 8% compared to 2014. Similarly for 2016, $CCI expects to deliver 8% growth in AFFO per share, up from $4.30 per share in 2015 to $4.66 per share in 2016, inclusive of about a 150 BP benefit from the sale of the Australian subsidiary and acquisition of Sunesys.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.